Monitoring risk: post marketing surveillance and signal detection.
about
Agonist Medications for the Treatment of Cocaine Use DisorderRisk management and post-marketing surveillance for the abuse of medications acting on the central nervous system: expert panel reportPrinciples of laboratory assessment of drug abuse liability and implications for clinical development.Role of key informants and direct patient interviews in epidemiological studies of substance abuse.Conference on abuse liability and appeal of tobacco products: conclusions and recommendations.Patterns of prescription opioid abuse and comorbidity in an aging treatment populationPostmarketing surveillance for "modified-risk" tobacco productsMultiple Determinants of Specific Modes of Prescription Opioid DiversionDevelopment and Application of an Alert System to Detect Cases of Food Poisoning in Japan.Public Health Effects of Medical Marijuana Legalization in Colorado.Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations.Nonmedical use of prescription ADHD stimulants and preexisting patterns of drug abusePatterns of abuse and routes of administration for immediate-release hydrocodone combination products.Changes in drug use patterns reported on the web after the introduction of ADF OxyContin: findings from the Researched Abuse, Diversion, and Addiction-Related Surveillance (RADARS) System Web Monitoring Program.Drug availability adjustments in population-based studies of prescription opioid abuse.Diversion and injection of buprenorphine-naloxone film two years post-introduction in Australia.OPPIDUM surveillance program: 20 years of information on drug abuse in France.Which psychoactive prescription drugs are illegally obtained and through which ways of acquisition? About OPPIDUM survey.Misuse of buprenorphine maintenance treatment since introduction of its generic forms: OPPIDUM survey.
P2860
Q28087404-7E06525A-48E2-491F-8942-AD2203352751Q33748353-4362FD6E-5DB4-4032-916B-E71C4BD82340Q34981070-198E4402-C513-4DC1-BD90-E91A3AD045B8Q34981568-DDA1B032-06E2-4A3D-A3BF-7C6CCEC80F7EQ35017158-1F68B2C6-DA6C-4BA2-82C3-D5DBC06A87B0Q35552548-D65D3DF8-64F2-403D-BC05-A0CFD9B8FC89Q35624464-9F877727-BDE4-4EB3-A303-56759D13C20BQ35691720-A18651F7-E892-428D-B519-AC3AF13ECB00Q36032190-68C0B6F5-648D-4AF8-811F-F7B238E54E07Q36604749-7D645A26-0769-434A-B35B-65A7D3E765DBQ36742039-3F936391-52EA-492F-BA22-58C5AFA06316Q36778727-7030369F-152B-4364-8E3E-0C92A5662A80Q38644058-F2C4A307-1379-480F-9127-3013AA91EE28Q38707436-4FE0006E-9893-4682-AA77-591921DA3C55Q40414322-4ACB9995-852F-4649-B60C-699D763E9DD5Q40450431-75D36DDE-1812-4F31-9670-11F5A5D201E1Q43561603-685084B8-73E8-40AB-A618-18798FB42769Q51163942-C5151FFE-34FE-4D9B-BDA8-6A62A434C9C5Q51173415-2183A1EA-190C-4E1E-8055-6C5408A67580
P2860
Monitoring risk: post marketing surveillance and signal detection.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Monitoring risk: post marketing surveillance and signal detection.
@en
Monitoring risk: post marketing surveillance and signal detection.
@nl
type
label
Monitoring risk: post marketing surveillance and signal detection.
@en
Monitoring risk: post marketing surveillance and signal detection.
@nl
prefLabel
Monitoring risk: post marketing surveillance and signal detection.
@en
Monitoring risk: post marketing surveillance and signal detection.
@nl
P1476
Monitoring risk: post marketing surveillance and signal detection.
@en
P2093
Richard C Dart
P304
P356
10.1016/J.DRUGALCDEP.2009.08.011
P478
105 Suppl 1
P577
2009-09-12T00:00:00Z